510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K192046Substantially Equivalent

LIAISON XL Zika Capture IgM II and LIAISON XL Zika Capture IgM II Control Set

Diasorin Inc., Stillwater MN / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K192046 is the FDA 510(k) clearance record for LIAISON XL Zika Capture IgM II and LIAISON XL Zika Capture IgM II Control Set, a class II device, cleared for DiaSorin, Inc. on under FDA product code QFO (Zika Virus Serological Reagents). FDA's definition for product code QFO reads: "Zika virus serological reagents are devices that consist of antigens and antisera for the diagnosis of Zika virus infection in human clinical specimens from individuals that have signs and symptoms consistent with Zika virus infection...". FDA records list 74 510(k) clearances for DiaSorin, Inc., from to . As of , FDA records show no recalls naming K192046.

Clearance record

Decision date
Received
(89 days to decision)
Product code
QFO Zika Virus Serological Reagents
Regulation
21 CFR 866.3935
Device class
Class II
Review panel
Microbiology
Applicant
DiaSorin, Inc. 1951 Northwestern Ave., Stillwater MN
510(k) summary
Summary PDF
Third party review
No

Clearances, product code QFO

Trailing 12 months

FDA records hold no clearances under product code QFO in the trailing twelve months.

FDA records show no clearances under product code QFO in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code QFO, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260